Balance Sheet for Alnylam Pharmaceuticals Inc. (ALNY)

$ 135.27   2.17 (+1.63%) Volume: 869.81k 4:00 PM EDT 29-May-2020
After Hours:  $ 135.27 0.00 (0.00%) Volume: 102.05k 5:26 PM EDT 29-May-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 547 420 645 194 181
Restrictable Cash - - - - -
Marketable Securities 989 664 1,045 433 900
Accounts Receivable 43 19 34 23 8
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 43 19 34 23 8
Inventories, Raw Materials 15 9 - - -
Inventories, Work in Progress 38 15 - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 3 0 - - -
Inventories, Other 56 24 - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 56 24 - - -
Prepaid Expenses 80 74 40 22 17
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 1,716 1,201 1,765 672 1,105
Land and Improvements 9 9 9 9 -
Buildings and Improvement 383 66 51 45 36
Machinery, Furniture and Equipment 55 64 56 53 42
Construction in Progress 54 261 134 68 1
Fixed Assets, Other 221 - - - -
Fixed Assets, Total 723 400 249 176 79
Gross Fixed Assets 723 400 249 176 79
Accumulated Depreciation (76) (79) (67) (61) (51)
Net Fixed Assets 646 321 182 115 28
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 33 53 4 2 1
Total Non-Current Assets 679 374 230 591 281
Total Assets 2,395 1,575 1,995 1,263 1,387
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 50 60 28 54 15
Short Term Debt 28 - - - -
Notes Payable - - - - -
Accrued Expenses 129 75 38 28 18
Accrued Liabilities 129 75 38 28 18
Deferred Revenues 78 3 42 34 15
Current Deferred Income Taxes - - - - -
Other Current Liabilities 68 41 36 15 14
Total Current Liabilities 353 179 144 132 62
Long Term Debt 60 30 30 150 -
Deferred Income Tax 318 58 50 58 58
Other Non-Current Liabilities 268 63 54 61 60
Minority Interest - - - - -
Capital Lease Obligations 276 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 604 93 84 211 60
Total Liabilities 956 273 228 343 122
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 1,439 1,302 1,766 920 1,265
Common Par 1 1 1 1 1
Additional Paid in Capital 5,201 4,175 3,948 2,610 2,506
Cumulative Translation Adjustments - - - - -
Retained Earnings (3,727) (2,841) (2,148) (1,657) (1,247)
Treasury Stock - - - - -
Other Equity Adjustments (37) (33) (34) (33) 4
Total Capitalization 1,499 1,332 1,796 1,070 1,265
Total Equity 1,439 1,302 1,766 920 1,265
Total Liabilities & Shareholder's Equity 2,395 1,575 1,995 1,263 1,387
Cash Flow (886) (761) (491) (410) (290)
Working Capital 1,363 1,021 1,620 540 1,043
Free Cash Flow (419) (690) (487) (372) (202)
Invested Capital 1,439 1,332 1,796 1,070 1,265
Shares Outstanding - Common Class Only 112 101 100 86 85
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 112 101 100 86 85
Total Common Shares Outstanding 112 101 100 86 85
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 109 101 91 86 84
Diluted Weighted Shares Outstanding 109 101 91 86 84